home All News open_in_new Full Article

Xenon to Report Q2 2025 Financial Results on August 11, 2025

VANCOUVER, British Columbia and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced it will report its second quarter 2025 financial results and provide a business update after the close of U.S. financial markets […]


today 1 week ago attach_file Other

attach_file Economics
attach_file Other
attach_file Transport
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 3520031834
Add Watch Country

arrow_drop_down